(Q51541991)

6 April 2018

title

Insulin-like growth factors and risk of benign prostatic hyperplasia. (English)

1 reference

6 April 2018

1 reference

2

Yu-Tang Gao

1 reference

6 April 2018

Frank Z. Stanczyk

4

object named as

Frank Z Stanczyk

1 reference

6 April 2018

author name string

Anand P Chokkalingam

1

1 reference

6 April 2018

Jie Deng

3

1 reference

6 April 2018

Isabell A Sesterhenn

5

1 reference

6 April 2018

F K Mostofi

6

1 reference

6 April 2018

Joseph F Fraumeni

7

1 reference

6 April 2018

Ann W Hsing

8

1 reference

6 April 2018

publication date

1 July 2002

1 reference

6 April 2018

published in

The Prostate

1 reference

6 April 2018

volume

52

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

98-105

1 reference

6 April 2018

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Circulating Insulin-like Growth Factor-I and Benign Prostatic Hyperplasia - A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

The development of human benign prostatic hyperplasia with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10096

21 January 2018

Identifiers

DOI

10.1002/PROS.10096

1 reference

6 April 2018

1 reference

6 April 2018